How to clinically assess and treat muscle overactivity in spastic paresis

Journal of Rehabilitation Medicine

Volumn 42, Issue 9, 2010, Pages 801-807

  Yelnik, Alain P ^a   Simon, Olivier ^a   Parratte, Bernard ^b   Gracies, Jean Michel ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Assessment; Muscle overactivity; Spastic paresis; Treatment

Indexed keywords

BOTULINUM TOXIN A; NEUROMUSCULAR BLOCKING AGENT;

ADULT; BRAIN INJURY; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; PARESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYSIOTHERAPY; REVIEW; SPASTICITY; STROKE;

ADULT; BOTULINUM TOXIN TYPE A; BRAIN INJURIES; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR BLOCKING AGENTS; PARESIS; PHYSICAL THERAPY MODALITIES; RANGE OF MOTION, ARTICULAR; STROKE;

EID: 77957352798     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0613     Document Type: Review

References (51)

1. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005;31:535-551.
2. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005;31:552-571.
3. Baptista IL, Leal ML, Artioli GG, Aoki MS, Fiamoncini J, Turri AO, et al. Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. Muscle Nerve 2010;41:800-808.
4. Maier IC, Baumann K, Thallmair M, Weinmann O, Scholl J, Schwab ME. Constraint induced movement therapy in the adult rat after unilateral corticospinal tract injury. J Neurosci 2008;28:9386-9403.
5. Raineteau O, Schwab ME. Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2001;2:263-273. (Pubitemid 33673067)
6. Lance JW, Feldman RG, Young RR, Koeller C. Spasticity: disorder of motor control. Chicago, IL: Year Book Medical; 1980, p. 485-494.
7. Denny-Brown D. The cerebral control of movement. Liverpool: University Press; 1966, p. 124-143.
8. Gracies JM, Wilson L, Gandevia SC, Burke D. Stretched position of spastic muscles aggravates their co-contraction in hemiplegic patients. Ann Neurol 1997;42:438-439.
9. Crone C, Johnsen LL, Biering-Sorensen F, Nielsen JB. Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury. Brain 2003;126:495-507. (Pubitemid 36172753)
10. Knutsson E, Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain 1979;102:405-430. (Pubitemid 9161011)
11. Patrick E, Ada L. The Tardieu Scale differentiates contracture from spasticity whereas the Ashworth Scale is confounded by it. Clin Rehabil 2006;20:173-182.
12. Gracies JM, Burke K, Clegg NJ, Browne R, Rushing C, Fehlings D, et al. Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil 2010;91:421-428.
13. Fimbel EJ, Domingo PP, Lamoureux D, Beuter A. Automatic detection of movement disorders using recordings of rapid alternating movements. J Neurosci Methods 2005;146:183-190. (Pubitemid 41373456)
14. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000;69:217-221. (Pubitemid 30466027)
15. Brashear A, Gordon MF, Elovic E. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400. (Pubitemid 34851831)
16. Wade DT, Langton-Hewer R, Wood VA, Skilbeck CE, Ismail HM. The hemiplegic arm after stroke: measurement and recovery. J Neurol Neurosurg Psychiat 1983;46:521-524. (Pubitemid 13099699)
17. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. A method for evaluation of physical performance. Scand J Rehab Med 1975;7:13-31.
18. Lindmark B, Hamrin E. Evaluation of functional capacity after stroke as a basis for active intervention. Validation of a modified chart for motor capacity assessment. Scand J Rehabil Med 1988;20:111-115.
19. Simpson DM, Alexander DN, O'Brien CF. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, doubleblind, placebo-controlled trial. Neurology 1996;46:1306-1310. (Pubitemid 26159292)
20. Rousseaux M, Kozlowski O, Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. J Neurol 2002;249:76-84. (Pubitemid 34119027)
21. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebocontrolled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13. (Pubitemid 30072216)
22. Richardson D, Sheean G, Werring D. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 2000;69:499-506.
23. Bakheit AM, Thilmann AF, Ward AB. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000;31:2402-2406.
24. Gracies JM, Hefter H, Simpson D, Moore P. Botulinum toxin in spasticity. In: Moore P, Naumann M, editors. Handbook of Botulinum toxin. Oxford: Blackwell Science; 2002, p. 221-274.
25. Bakheit AM, Pittock S, Moore A P. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001;8:559-565. (Pubitemid 35015221)
26. Butler P, Engelbrecht M, Major RE, Tait JH, Stallard J, Patrick JH. Physiological cost index of walking for normal children and its use as an indicator of physical handicap. Dev Med Child Neurol 1984;26:607-612. (Pubitemid 14002376)
27. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-542.
28. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther 1987;67:206.
29. Nielsen JF, Sinkjaer T. A comparison of clinical and laboratory measures of spasticity. Mult Scler 1996;1:296-301. (Pubitemid 126701322)
30. Yelnik AP, Simon O, Bensmail D, Chaleat-Valayer E, Decq P, Dehail P, et al. Drug treatments for spasticity. Ann Phys Rehabil Med 2009;52:746-756.
31. AFSSAPS. [cited 2010 July 7] Available from: http://www.afssaps. fr/var/afssaps-site/storage/original/application/ a79f07eee915181bc9ae4e506140cecb.pdf.
32. Yelnik AP, Albert T, Bonan I, Laffont I. A clinical guide to assess the role of lower limb extensor overactivity in hemiplegic's gait disorders. Stroke 1999;30:580-585. (Pubitemid 29115395)
33. Filipetti P, Decq P. L'apport des blocs anesthésiques dans l'évaluation du patient spastique. A propos d'une série de 815 blocs moteurs. Neurochirurgie 2003;49:226-238. (Pubitemid 36541916)
34. Buffenoir K, Rigoard P, Lefaucheur JP, Filipetti P, Decq P. Lidocaine hyperselective motor blocks of the triceps surae nerves: role of the soleus versus gastrocnemius on triceps spasticity and predictive value of the soleus motor block on the result of selective tibial neurotomy. Am J Phys Med Rehabil 2008;87:292-304. (Pubitemid 351450747)
35. Watanabe T. The role of therapy in spasticity management. Am J Phys Med Rehabil 2004;83:S45-S49. (Pubitemid 39281268)
36. Gracies JM. Physical modalities other than stretch in spastic hypertonia. Phys Med Rehabil Clin N Am 2001;12:769-792.
37. Bovend'Eerdt TJ, Newman M, Barker K, Dawes H, Minelli C, Wade DT. The effects of stretching in spasticity: a systematic review. Arch Phys Med Rehabil 2008;89:1395-1406. (Pubitemid 351884984)
38. Ring H, Weingarden H. Neuromodulation by functional electrical stimulation (FES) of limb paralysis after stroke. Acta Neurochir Suppl 2007;97(Pt 1):375-380.
39. Kimberley TJ, Lewis SM, Auerbach EJ, Dorsey LL, Lojovitch JM, Carey JR. Electrical stimulation driving functional improvements and cortical changes in subjects with stroke. Exp Brain Res 2004;154:450-460. (Pubitemid 38293735)
40. Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A; BoNT/TZD Study Team. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. J Neurol Neurosurg Psychiatry 2009;80:380-385.
41. Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm 2008;115:617-623.
42. Rousseaux M, Compère S, Launay MJ, Kozlowski O. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles. J Neurol Sci 2005;15:51-57. (Pubitemid 40585842)
43. Bensmail D, Robertson J, Fermanian C, Roby-Brami A. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: grasp strategies and kinematics of reach-to-grasp movements. Neurorehabil Neural Repair 2010;24:273-281.
44. Geenen C, Consky E, Ashby P. Localizing muscles for botulinum toxin treatment of focal hand dystonia. Can J Neurol Sci 1996;23:194-197. (Pubitemid 26302746)
45. Smith MB, Brar SP, Nelson LM, Franklin GM, Cobble ND. Baclofen effect on quadriceps strength in multiple sclerosis. Arch Phys Med Rehabil 1992;73:237-240.
46. United Kingdom Tizanidine Trial Group. A double-blind, placebocontrolled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. Neurology 1994;44:S70-S78.
47. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236-240.
48. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil 2006;87:1509-1515. (Pubitemid 44647181)
49. Gracies JM, Nance P, Elovic E, McGuire J, Simpson D. Traditional pharmacologic treatments of spasticity - Part II systemic treatments. In: Mayer NH, Simpson DM, editors. Spasticity: etiology, evaluation, management and the role of botulinum toxin. New York: We Move; 2002, p. 65-93.
50. Sindou M, Mertens P. Selective neurotomy of the tibial nerve for treatment of the spastic foot. Neurosurgery 1988;23:738-744. (Pubitemid 19018776)
51. Maarrawi J, Mertens P, Luaute J, Vial C, Chardonnet N, Cosson M, et al. Long-term functional results of selective peripheral neurotomy for the treatment of spastic upper limb: prospective study in 31 patients. J Neurosurg 2006;104:215-225.